{"id":8365,"date":"2023-10-26T14:29:27","date_gmt":"2023-10-26T12:29:27","guid":{"rendered":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf"},"modified":"2023-10-26T14:29:27","modified_gmt":"2023-10-26T12:29:27","slug":"231026_fr_maat-pharma-2","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/pharma-announces-positive-outcome-following-dsmb-review-reinforcing-confidence-in-phase-3-on-going-trial\/231026_fr_maat-pharma-2\/","title":{"rendered":"231026_FR_MaaT-Pharma"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-8365","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>231026_FR_MaaT-Pharma | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/231026_FR_MaaT-Pharma.pdf\",\"url\":\"https:\\\/\\\/www.seventure.fr\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/231026_FR_MaaT-Pharma.pdf\",\"name\":\"231026_FR_MaaT-Pharma | Seventure\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#website\"},\"datePublished\":\"2023-10-26T12:29:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/231026_FR_MaaT-Pharma.pdf#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.seventure.fr\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/231026_FR_MaaT-Pharma.pdf\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/231026_FR_MaaT-Pharma.pdf#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma announces positive outcome following DSMB review reinforcing confidence in phase 3 on-going trial.\",\"item\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/pharma-announces-positive-outcome-following-dsmb-review-reinforcing-confidence-in-phase-3-on-going-trial\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"231026_FR_MaaT-Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"231026_FR_MaaT-Pharma | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf","url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf","name":"231026_FR_MaaT-Pharma | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/#website"},"datePublished":"2023-10-26T12:29:27+00:00","breadcrumb":{"@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Pharma announces positive outcome following DSMB review reinforcing confidence in phase 3 on-going trial.","item":"https:\/\/www.seventure.fr\/en\/pharma-announces-positive-outcome-following-dsmb-review-reinforcing-confidence-in-phase-3-on-going-trial\/"},{"@type":"ListItem","position":3,"name":"231026_FR_MaaT-Pharma"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/en\/#website","url":"https:\/\/www.seventure.fr\/en\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf'>231026_FR_MaaT-Pharma<\/a><\/p>\n"},"caption":{"rendered":"<p>231026_FR_MaaT-Pharma<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{"filesize":869405,"sizes":{}},"post":8359,"source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_FR_MaaT-Pharma.pdf","_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media\/8365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=8365"}],"wp:attached-to":[{"embeddable":true,"post_type":"post","id":8359,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/8359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}